, TABLE OF CONTENT dt dt
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................ 4
dt dt dt dt dt dt dt dt dt dt
Chapter 2. Review of Basic Principles of Pharmacology ....................................................................................... 5
dt dt dt dt dt dt dt
Chapter 3. Rational Drug Selection...................................................................................................................... 11
dt dt dt dt
Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
dt dt dt dt dt dt dt
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
dt dt dt dt
Chapter 6. An Introduction to Pharmacogenomics............................................................................................... 19
dt dt dt dt dt
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
dt dt dt dt
Chapter 8. Herbal Therapies ................................................................................................................................ 28
dt dt dt
Chapter 9. Cannabis ............................................................................................................................................. 31
dt dt
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
dt dt
Chapter 11. Drugs Affecting the Autonomic Nervous System............................................................................. 38
dt dt dt dt dt dt dt
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................... 45
dt dt dt dt dt dt dt
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems................................................................... 53
dt dt dt dt dt dt dt dt
Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
dt dt dt dt dt dt
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
dt dt dt dt dt dt
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................ 69
dt dt dt dt dt dt dt dt dt
Chapter 17. Drugs Affecting the Immune System: Immunomodulators............................................................... 75
dt dt dt dt dt dt dt
Chapter 18. Drugs Affecting the Gastrointestinal System.................................................................................... 77
dt dt dt dt dt dt
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ..................... 80
dt dt dt dt dt dt dt dt dt dt dt
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................... 83
dt dt dt dt dt dt dt dt dt dt dt
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
dt dt dt dt dt dt
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................... 92
dt dt dt dt dt dt dt
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
dt dt dt dt dt dt
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................ 101
dt dt dt dt dt dt dt
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .......................................................... 105
dt dt dt dt dt dt dt dt dt dt
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................. 108
dt dt dt dt dt dt dt
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................... 111
dt dt dt dt dt dt dt dt dt
Chapter 28. Anemia ........................................................................................................................................... 113
dt dt
Chapter 29. Anxiety and Depression.................................................................................................................. 116
dt dt dt dt
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
dt dt dt dt
Chapter 31. Asthma and Allergy........................................................................................................................ 122
dt dt dt dt
Chapter 32. Chronic Obstructive Pulmonary Disease ........................................................................................ 125
dt dt dt dt dt
Chapter 33. Contraception ................................................................................................................................. 127
dt dt
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................... 130
dt dt dt dt dt
Chapter 35. Dermatological Conditions............................................................................................................. 134
dt dt dt
Chapter 36. Diabetes Management .................................................................................................................... 138
dt dt dt
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease........................................................................ 146
dt dt dt dt dt dt dt
Chapter 38. Headaches ...................................................................................................................................... 149
dt dt
Chapter 39. Heart Failure ................................................................................................................................... 153
dt dt dt
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................. 158
dt dt dt dt dt dt dt
Chapter 41. Menopausal Hormone Therapy ...................................................................................................... 161
dt dt dt dt
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
dt dt
Chapter 43. Hypertension .................................................................................................................................. 169
dt dt
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
dt dt dt dt
Chapter 45. Obesity ........................................................................................................................................... 177
dt dt
Chapter 46. Pain Management: Acute and Chronic Pain.................................................................................... 181
dt dt dt dt dt dt dt
Chapter 47. Pneumonia ...................................................................................................................................... 185
dt dt
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................. 187
dt dt dt dt dt dt
Chapter 49. Substance Use Disorders ................................................................................................................ 190
dt dt dt dt
Chapter 50. Tuberculosis ................................................................................................................................... 195
dt dt
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............. 197
dt dt dt dt dt dt dt dt dt dt dt dt
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
dt dt dt dt
Chapter 53. Women as Patients ......................................................................................................................... 203
dt dt dt dt
Chapter 54. Men as Patients ............................................................................................................................... 207
dt dt dt dt
Chapter 55. Pediatric Patients ............................................................................................................................ 209
dt dt dt
Chapter 57. Geriatric Patients ............................................................................................................................ 213
dt dt dt
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e dt dt dt dt Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
dt dt dt dt dt dt dt dt dt dt
MULTIPLE CHOICE dt
1. Nurse practitioner prescriptive authority is regulated by:
dt dt dt dt dt dt
A. The National Council of State Boards of Nursing
dt dt dt dt dt dt dt
B. The U.S. Drug Enforcement Administration
dt dt dt dt
C. The State Board of Nursing for each state
dt dt dt dt dt dt dt
D. The State Board of Pharmacy
dt dt dt dt
ANS: C d t PTS: d t d t 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber in
dt dt dt dt dt dt dt dt dt dt dt dt dt dt
clude:
A. Nurses know more about pharmacology than other prescribers because they take it bo
dt dt dt dt dt dt dt dt dt dt dt dt
th in their basic nursing program and in their APRN program.
dt dt dt dt dt dt dt dt dt dt
B. Nurses care for the patient from a holistic approach and include the patient in de
dt dt dt dt dt dt dt dt dt dt dt dt dt dt
cision-making regarding their care. dt dt dt
C. APRNs are less likely to prescribe narcotics and other controlled substances.
dt dt dt dt dt dt dt dt dt dt
D. APRNs are able to prescribe independently in all states, whereas a physician’s as
dt dt dt dt dt dt dt dt dt dt dt dt
sistant needs to have a physician supervising their practice.
dt dt dt dt dt dt dt dt
ANS: B d t PTS: d t d t 1
3. Clinical judgment in prescribing includes:
dt dt dt dt
A. Factoring in the cost to the patient of the medication prescribed
dt dt dt dt dt dt dt dt dt dt
B. Always prescribing the newest medication available for the disease process
dt dt dt dt dt dt dt dt dt
C. Handing out drug samples to poor patients dt dt dt dt dt dt
D. Prescribing all generic medications to cut costs dt dt dt dt dt dt
ANS: A d t PTS: d t d t 1
4. The process for choosing an effective drug for a disorder includes:
dt dt dt dt dt dt dt dt dt dt
A. Asking the patient what drug they think would work best for them
dt dt dt dt dt dt dt dt dt dt dt
B. Consulting nationally recognized guidelines for disease management dt dt dt dt dt dt
C. Prescribing medications that are available as samples before writing a prescription
dt dt dt dt dt dt dt dt dt dt
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
dt dt dt dt dt dt dt
ANS: B d t PTS: d t d t 1
5. Nonintentional nonadherence of drug therapy may occur due to: dt dt dt dt dt dt dt dt
A. Belief that medication does not work
dt dt dt dt dt
B. Adverse drug reactions dt dt
C. Chronic conditions that require daily therapy dt dt dt dt dt
D. Forgetfulness or distraction dt dt
ANS: D d t PTS: d t d t 1
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................ 4
dt dt dt dt dt dt dt dt dt dt
Chapter 2. Review of Basic Principles of Pharmacology ....................................................................................... 5
dt dt dt dt dt dt dt
Chapter 3. Rational Drug Selection...................................................................................................................... 11
dt dt dt dt
Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
dt dt dt dt dt dt dt
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
dt dt dt dt
Chapter 6. An Introduction to Pharmacogenomics............................................................................................... 19
dt dt dt dt dt
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
dt dt dt dt
Chapter 8. Herbal Therapies ................................................................................................................................ 28
dt dt dt
Chapter 9. Cannabis ............................................................................................................................................. 31
dt dt
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
dt dt
Chapter 11. Drugs Affecting the Autonomic Nervous System............................................................................. 38
dt dt dt dt dt dt dt
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................... 45
dt dt dt dt dt dt dt
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems................................................................... 53
dt dt dt dt dt dt dt dt
Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
dt dt dt dt dt dt
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
dt dt dt dt dt dt
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................ 69
dt dt dt dt dt dt dt dt dt
Chapter 17. Drugs Affecting the Immune System: Immunomodulators............................................................... 75
dt dt dt dt dt dt dt
Chapter 18. Drugs Affecting the Gastrointestinal System.................................................................................... 77
dt dt dt dt dt dt
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ..................... 80
dt dt dt dt dt dt dt dt dt dt dt
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................... 83
dt dt dt dt dt dt dt dt dt dt dt
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
dt dt dt dt dt dt
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................... 92
dt dt dt dt dt dt dt
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
dt dt dt dt dt dt
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................ 101
dt dt dt dt dt dt dt
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .......................................................... 105
dt dt dt dt dt dt dt dt dt dt
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................. 108
dt dt dt dt dt dt dt
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................... 111
dt dt dt dt dt dt dt dt dt
Chapter 28. Anemia ........................................................................................................................................... 113
dt dt
Chapter 29. Anxiety and Depression.................................................................................................................. 116
dt dt dt dt
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
dt dt dt dt
Chapter 31. Asthma and Allergy........................................................................................................................ 122
dt dt dt dt
Chapter 32. Chronic Obstructive Pulmonary Disease ........................................................................................ 125
dt dt dt dt dt
Chapter 33. Contraception ................................................................................................................................. 127
dt dt
Chapter 34. COVID-19: Acute and Chronic ...................................................................................................... 130
dt dt dt dt dt
Chapter 35. Dermatological Conditions............................................................................................................. 134
dt dt dt
Chapter 36. Diabetes Management .................................................................................................................... 138
dt dt dt
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease........................................................................ 146
dt dt dt dt dt dt dt
Chapter 38. Headaches ...................................................................................................................................... 149
dt dt
Chapter 39. Heart Failure ................................................................................................................................... 153
dt dt dt
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................. 158
dt dt dt dt dt dt dt
Chapter 41. Menopausal Hormone Therapy ...................................................................................................... 161
dt dt dt dt
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
dt dt
Chapter 43. Hypertension .................................................................................................................................. 169
dt dt
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
dt dt dt dt
Chapter 45. Obesity ........................................................................................................................................... 177
dt dt
Chapter 46. Pain Management: Acute and Chronic Pain.................................................................................... 181
dt dt dt dt dt dt dt
Chapter 47. Pneumonia ...................................................................................................................................... 185
dt dt
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................. 187
dt dt dt dt dt dt
Chapter 49. Substance Use Disorders ................................................................................................................ 190
dt dt dt dt
Chapter 50. Tuberculosis ................................................................................................................................... 195
dt dt
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............. 197
dt dt dt dt dt dt dt dt dt dt dt dt
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
dt dt dt dt
Chapter 53. Women as Patients ......................................................................................................................... 203
dt dt dt dt
Chapter 54. Men as Patients ............................................................................................................................... 207
dt dt dt dt
Chapter 55. Pediatric Patients ............................................................................................................................ 209
dt dt dt
Chapter 57. Geriatric Patients ............................................................................................................................ 213
dt dt dt
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e dt dt dt dt Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
dt dt dt dt dt dt dt dt dt dt
MULTIPLE CHOICE dt
1. Nurse practitioner prescriptive authority is regulated by:
dt dt dt dt dt dt
A. The National Council of State Boards of Nursing
dt dt dt dt dt dt dt
B. The U.S. Drug Enforcement Administration
dt dt dt dt
C. The State Board of Nursing for each state
dt dt dt dt dt dt dt
D. The State Board of Pharmacy
dt dt dt dt
ANS: C d t PTS: d t d t 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber in
dt dt dt dt dt dt dt dt dt dt dt dt dt dt
clude:
A. Nurses know more about pharmacology than other prescribers because they take it bo
dt dt dt dt dt dt dt dt dt dt dt dt
th in their basic nursing program and in their APRN program.
dt dt dt dt dt dt dt dt dt dt
B. Nurses care for the patient from a holistic approach and include the patient in de
dt dt dt dt dt dt dt dt dt dt dt dt dt dt
cision-making regarding their care. dt dt dt
C. APRNs are less likely to prescribe narcotics and other controlled substances.
dt dt dt dt dt dt dt dt dt dt
D. APRNs are able to prescribe independently in all states, whereas a physician’s as
dt dt dt dt dt dt dt dt dt dt dt dt
sistant needs to have a physician supervising their practice.
dt dt dt dt dt dt dt dt
ANS: B d t PTS: d t d t 1
3. Clinical judgment in prescribing includes:
dt dt dt dt
A. Factoring in the cost to the patient of the medication prescribed
dt dt dt dt dt dt dt dt dt dt
B. Always prescribing the newest medication available for the disease process
dt dt dt dt dt dt dt dt dt
C. Handing out drug samples to poor patients dt dt dt dt dt dt
D. Prescribing all generic medications to cut costs dt dt dt dt dt dt
ANS: A d t PTS: d t d t 1
4. The process for choosing an effective drug for a disorder includes:
dt dt dt dt dt dt dt dt dt dt
A. Asking the patient what drug they think would work best for them
dt dt dt dt dt dt dt dt dt dt dt
B. Consulting nationally recognized guidelines for disease management dt dt dt dt dt dt
C. Prescribing medications that are available as samples before writing a prescription
dt dt dt dt dt dt dt dt dt dt
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
dt dt dt dt dt dt dt
ANS: B d t PTS: d t d t 1
5. Nonintentional nonadherence of drug therapy may occur due to: dt dt dt dt dt dt dt dt
A. Belief that medication does not work
dt dt dt dt dt
B. Adverse drug reactions dt dt
C. Chronic conditions that require daily therapy dt dt dt dt dt
D. Forgetfulness or distraction dt dt
ANS: D d t PTS: d t d t 1
